REPEATED MORPHINE ADMINISTRATION DOWN-REGULATES GLUCOCORTICOID, BUT NOT MINERALOCORTICOID, RECEPTORS IN THE RAT HIPPOCAMPUS

被引:13
作者
BUDZISZEWSKA, B [1 ]
JAWORSKA, L [1 ]
LASON, W [1 ]
机构
[1] POLISH ACAD SCI,INST PHARMACOL,DEPT ENDOCRINOL,PL-31343 KRAKOW,POLAND
关键词
MORPHINE; CORTICOSTEROID RECEPTORS; HIPPOCAMPUS; CORTICOSTERONE; PLASMA; RAT;
D O I
10.1016/0306-4530(94)E0043-9
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Activation of the hypothalamic-pituitary-adrenal axis (HPA) is known to be an important component of a neuroendocrine response to opiates. Since this axis is under inhibitory control of hippocampal corticosteroid receptors, the present study has been designed to determine the effects of single (20 mg/kg IP) and repeated (from 20 to 100 mg/kg/day, IP, twice a day for 10 days) morphine administration on binding parameters of these receptors. Glucocorticoid (GR) and mineralocorticoid (MR) receptors were examined by an in vitro [H-3]-corticosterone binding in the cytosol from the rat hippocampus, using the selective GR agonist RU 28362 to discriminate between MR and GR. Repeated, but not single, treatment with morphine significantly (by similar to 22%) reduced the density of GR at 2 h and tended to decrease it at 72 h after the last drug injection. The density of MR was unchanged at those time points. No changes in dissociation constants of either type of the receptors were found following single or repeated morphine administration. The plasma corticosterone level was significantly increased 1 h after acute and chronic administration of morphine (382 and 527%, respectively). These results indicate that repeated morphine administration downregulates GR receptors, which may impair the feedback control mechanism of the HPA activity.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 38 条
[1]
AHTEE L, 1989, J PHARMACOL EXP THER, V249, P303
[2]
TISSUE-SPECIFIC DOPAMINERGIC REGULATION OF THE GLUCOCORTICOID RECEPTOR IN THE RAT PITUITARY [J].
ANTAKLY, T ;
MERCILLE, S ;
COTE, JP .
ENDOCRINOLOGY, 1987, 120 (04) :1558-1562
[4]
PHARMACOLOGICAL CHARACTERIZATION OF OPIOID RECEPTORS INFLUENCING THE SECRETION OF CORTICOTROPIN RELEASING-FACTOR IN THE RAT [J].
BUCKINGHAM, JC ;
COOPER, TA .
NEUROENDOCRINOLOGY, 1986, 44 (01) :36-40
[5]
BUDZISZESKA B, 1993, EUR J NEUROPHARMACOL, V3, P411
[6]
THE MESOLIMBIC DOPAMINERGIC SYSTEM EXERTS AN INHIBITORY INFLUENCE ON BRAIN CORTICOSTEROID RECEPTOR AFFINITIES [J].
CASOLINI, P ;
PIAZZA, PV ;
KABBAJ, M ;
LEPRAT, F ;
ANGELUCCI, L ;
SIMON, H ;
LEMOAL, M ;
MACCARI, S .
NEUROSCIENCE, 1993, 55 (02) :429-434
[7]
DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95
[8]
DEROCHE V, 1993, BRAIN RES, V611, P351
[9]
EISENBERG RM, 1979, J PHARMACOL EXP THER, V2, P364
[10]
ELDRIDGE JC, 1989, BRAIN RES, V478, P248